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ABSTRACT 
The causative agents of animal trypanosomosis are various species of protozoan parasites belonging to 
the genus Trypanosoma, among which T. congolense and T. evansi are the major pathogenic species. 
The extra cellular position of the trypanosomes implies to consider both the parasite and its excreted-
secreted factors in the course of the physiopathological processes. Proteome (i.e. parasite constitutive 
proteins) and secretome (i.e. naturally excreted-secreted proteins) analysis need to be conducted in 
parallel to identify key trypanosome’s proteins potentially involved in both virulence and 
pathogenicity. We developed and standardised a method to produce purified proteome and secretome 
of the two sub-genus Trypanozoon and Nannomonas. The protocol is based on the production of 
trypanosome bloodstream forms by infection of naturally immunosupressed rodents (Nude/SOPF®) 
and incubated in a defined secretion medium that mimics the blood biochemical environment deprived 
of cells and macromolecules. Supernatants representing secretome are separated from parasites pellets 
representing proteome by centrifugation and filtration and both are conditioned for further analysis in 
two-dimensional gel electrophoresis and mass spectrometry. The defined secretion medium appears to 
reduced expression of stress proteins. Two-dimensional difference gel electrophoresis (2-D DIGE) 
analysis of secretomes in particular confirmed both the differences observed in 1-D gels and the high 
reproducibility between secretome batches of a same trypanosome strain. The molecular identification 
of differentially expressed trypanosomes molecules correlated with either the virulence process or the 
pathogenicity will provide new potential molecular targets. 
 
 
INTRODUCTION 
Trypanosomes are the causative agents of the Human African Trypanosomosis (HAT) or sleeping 
sickness, and of animal trypanosomosis also called “Nagana”. Nagana slows down the development of 
breeding in 37 countries located in the most productive areas of the sub-saharian Africa (FAO, 2007). 
Fifty millions bovines and seventy millions small ruminants are estimated to be exposed. The 
consequence of this situation is the concentration of the breeding in the semi-arid zones with limited 
fodder resources.  
Mammals can be infected by several pathogenic species of trypanosomes belonging to the three sub-
genuses: Trypanosoma brucei brucei and Trypanosoma evansi for Trypanozoon, Trypanosoma vivax 
for Dutonella, Trypanosoma congolense and Trypanosoma simiae for Nannomonas. The main 
symptoms are: hyperthermia, hypertrophy of several organs, anaemia caused by haemolysis and 
erythropoïesis failure, degenerative, myocarditis and endocrinal troubles, Cachexy and reproduction 
troubles. The evolution of the sickness depends on the parasitemia, the host’s sensitivity and its 
environment. 
The concept of our study concerns the time of the infection in mammals, particularly the cell-cell 
interactions and the soluble factors released in the host’s blood. On one hand, the trypanosome 
develops strategies to escape the immune response, on the other hand, due to the extra cellular 
localization; the trypanosome produces constitutive factors and excreted-secreted products (ESP), all 
factors leading to infection (De Souza, 2006). We distinguish two kinds of ESP: those actively 
secreted from the cytoplasm by the way of the flagellar pocket, and those directly excreted from the 
outer membrane. We developed a standardized method to characterize new molecular targets. This 
approach allowed us analyzing the proteome and the secretome of animal trypanosomes, illustrated 
here with T. congolense. 
 
METHODS 
In a first time the method was tested with two T. congolense strains of the savannah type: IL1180 and 
IL3000, well known for their opposite virulence (Nantulya et al., 1984). This behaviour which has 
been observed in bovines during several trials in the field was reproduced successfully in rodents, so 
that rodents could be retained as an infection model. 
The first step of the experimental schedule consisted in the infection of Nude SOPF rats (Charles 
River Laboratories): 250µl of cryoconserved and infected blood containing from a ¼ to ½ million of 
trypanosomes were injected intraperitoneally. Parasitemia was checked daily by microscopic 
examination of a drop of blood (Herbert & Lumsden, 1976). Blood was collected as soon as the 
parasitemia reached 250×10
6
 parasites per millilitre. The bloodstream forms were purified under 
sterile conditions using a DEAE cellulose column and phosphate buffer saline plus 1% glucose (PSG) 
at pH8 (Lanham & Godfrey, 1970). Then, the parasites were washed and concentrated by 
centrifugation, 3 times successively.  
After purification the trypanosomes were incubated during 2 hours at 37°C and 5% CO2 in a special 
secretion medium (Holzmuller et al., 2007) at the concentration of 200×10
6
 parasites per millilitre. The 
viability and number of trypanosomes were monitored by flow cytometry every 15 minutes. After 
incubation the secretome was centrifuged and the supernatant was filtered on a 0,22 µm low-protein-
binding filter. Anti-proteases (Complete cocktail, Roche) were added to both parasite pellet and 
secretome before storage at -80°C. 
Following production, secretomes and whole parasite extracts (proteome) were submitted to a 
proteomic analysis. In a first step, the quality of the products has been tested using 1-Dimensionnal 
electrophoresis in a Trycine 12.5% polyacrylamide gel and the identification by mass spectrometry 
(MS-MS, Q-Trap 4000®, Applied Biosystem) was performed after automatic picking of the protein 
bands. In parallel, a 2-Dimensionnal electrophoresis was performed for a comparative mapping issue 
with DIGE method (Marouga et al., 2005). 
  
RESULTS 
Difference of virulence and pathogenicity of T. congolense strains in bovine and Nude 
rats. Infection courses in both trypanosusceptible bovines (Table 1) and Nude rats (Figure 1) were 
monitored and compared between T. congolense IL1180 and IL3000 strains. T. congolense IL1180 
exhibited a first parasitemia about 2 times delayed and 2-fold lower compared with IL3000. Moreover, 
the lower virulence of IL1180 was correlated with a survival rate of 80% of the mice in the time 
course of the experiment (i. e. 1 month) compared to full mortality induced by IL3000 (Figure 1).  
T. congolense 
strain 
Prepatent period 
average (days) 
Parasitemia average (× 10
6
 trypanosomes 
per ml of blood) 
IL1180 11.20 ± 0.7 71.14 ± 16.36 
IL3000 9.50 ± 0.3 121.39 ± 77.39 
Table 1. Clinical follow-up of 1.5-2 old years heifers from north Burkina Faso (trypanosomes-free 
area) subcutaneously injected (by syringe) with 10
5
 tryps/animal derived from in vivo culture in NMRI 
mice. Parasitemia was evaluated every 2 days on a fresh drop of blood. 
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Figure 1. Clinical follow-up for virulence and pathogenicity of T. congolense strains in Nude rats. 
After intraperitoneal inoculation of about 100×10
6
 trypanosomes, evolution of infection was 
monitored considering parasitemia (curves) and survival level (bars) reached in the time course of the 
experiment (1 month). 
 
Differential profiles of T. congolense strains secretomes and molecular characterisation 
Viability of T. congolense was higher than 97% after 2 hours in the secretion medium, and the parasite 
concentration remain stable. For each strain, differentially expressed specific bands potentially 
involved in virulence or pathogenicity are observed in 1D Trycine-PAGE (Figure 2).  
 Figure 2. 1-D Trycine-PAGE profiles of T. congolense secretomes. Arrows indicate protein bands 
differentially expressed between strains. 
 
Each band was automatically picked and the molecular characterisation by mass spectrometry led to 
identification of 88 proteins in T. congolense secretome. Unfortunately, 18.2% were defined as 
hypothetical proteins in the databases. Nevertheless, some have been recently described for their 
vaccine properties or as therapeutic targets, e.g. the eukaryotic translation initiation factor 5A, eIF-5A 
(Park, 2006) or the triosephosphate isomerase TIM (Olivares-Illana et al., 2006). Interestingly, at least 
half of the secreted proteins identified are directly involved in the processes influencing parasite 
virulence with the major parts belonging to important metabolic functions: proteases, chaperonins, 
carbohydrates degradation, nucleotides uptake or energetic metabolism (Figure 3). 
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Figure 3. Graphic representation of the functions of T. congolense strains secretomes components 
after molecular characterisation by mass spectrometry. 
 
Comparative mapping of T. congolense strains proteomes and secretomes. Despite different 
staining methods, T. congolense proteome stained with colloidal Coomassie blue exhibit a different 
2D map of constitutive proteins compared to secretome stained with fluorescent CyDye (Figure 4).  
 
Figure 4. Two-dimensional mapping of T. congolense proteome and secretome 
Nevertheless, a spot-by-spot comparison demonstrated that the relationship between both T. 
congolense stocks (i) for the area of common protein spots is significant with a high correlation 
coefficient (r = 0.963, R
2
 = 0.919), and (ii) for the intensity of common protein spots is significant 
with a low correlation coefficient (r = 0.634, R
2
 = 0.378), suggesting that plasticity in expression of 
the same molecules could lead to different infectious abilities. 
 
DISCUSSION-CONCLUSION 
Considering the extra cellular localisation of trypanosomes, the success of the infectious process is 
based on molecular “crosstalk” with the host’s immune cells. By analyzing the secretome of two 
different strains of T. congolense we were able to characterize common and specific proteins used by 
the parasite for its invading strategy. As in the initial work with T. b. gambiense (Holzmuller et al., 
2007), in this study we first characterised strains of both T. congolense with differing virulence and 
pathogenicity in the experimental Nude rat model. This constituted a strong base for the use of 
proteomics analysis to characterise parasite virulence factors. As in recent studies that demonstrated 
differential protein expression of glycosome’s content during the parasite life cycle (Colasante et al., 
2006) or between drug-sensitive and drug-resistant isogenic lines (Foucher et al., 2006) the 
comparative approach allowed us to evidence quantitative differences between the secretome of the 
two strains that could be correlated with virulence and pathogenicity, and lead to discriminate new key 
molecules of the infectious process. Although, our standardized method still requires improvement, 
especially because most of the identified proteins referred to the genome of T. brucei, which is the 
only available and complete annotated one. Referring to the genome of T. congolense should 
strengthen our model, and may also contribute to highlight molecular differences between 
Trypanosome species. Another difficulty, knowing that many proteins have several functions, is to 
choose the most relevant one as a potential therapeutic target. For instance, the kinetoplastid 
membrane protein KMP11 is involved in the defence response as well as in the positive regulation of 
cell proliferation. Nevertheless, as shown for Human African Trypanosomosis (Papadopoulos et al., 
2004), this technology may contribute also to improve the diagnosis of animal trypanosomosis. To 
conclude in a prospective manner, ongoing researches on the secretome and proteome of 
trypanosomes aim at characterising common and species-specific proteins, either differentially 
expressed in correlation with virulence and pathogenicity to define new therapeutic targets or 
differentially recognised by host immune system to define new diagnostic tools. 
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